EMD-503982

CAS No. 768370-75-8

EMD-503982( —— )

Catalog No. M34238 CAS No. 768370-75-8

EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EMD-503982
  • Note
    Research use only, not for human use.
  • Brief Description
    EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.
  • Description
    EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Factor Xa
  • Recptor
    Factor Xa
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    768370-75-8
  • Formula Weight
    458.9
  • Molecular Formula
    C22H23ClN4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1=CC=C(C=C1)N2C(=O)COCC2)(=O)[C@@H]3N(C(NC4=CC=C(Cl)C=C4)=O)C[C@H](O)C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Garadacimab

    Garadacimab (CSL312) is a potent whole-human IgG4 monoclonal antibody targeting activation factor XII (FXIIa). Garadacimab can be used to study hereditary angioedema.

  • Razaxaban

    A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM.

  • Zifaxaban

    Zifaxaban (TY-602) is an orally active, competitive and selective inhibitor of factor Xa (FXa) with an IC50 of 11.1 nM for human FXa.Zifaxaban has a very high affinity, more than 10,000-fold higher than that of other serine proteases.Zifaxaban can be used to study arterial and venous thrombosis.